TapewireFind a company

person · Reporting owner

CROWTHER BRUCE K

Disclosed activity across 3 companies

Tapewire entity
75227
SEC CIK
0001244274

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
METHODE ELECTRONICS INCMEI · Entity 1870DirectorSeptember 22, 2026September 24, 2026
NEOGENOMICS INCNEO · Entity 2096DirectorAugust 10, 2023August 14, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

METHODE ELECTRONICS INC

Report date September 22, 2026 · Filed September 24, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct9,186 Reported balance After 2026-09-22 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-09-22 · Grant · Acquired 9,186 · Balance 9,186

F1: Each restricted stock unit represents a contingent right to receive one share of Methode common stock upon vesting, granted under the Company's 2026 Omnibus Incentive Plan.

F2: The restricted stock units vest in full on the date of the Company's 2027 annual meeting of shareholders.

Common StockSEC Table I · non-derivativeIndirectIn Trust50,654 Reported balance Holding disclosure · report date 2026-09-22 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 50,654

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of Methode common stock upon vesting, granted under the Company's 2026 Omnibus Incentive Plan.

F2: The restricted stock units vest in full on the date of the Company's 2027 annual meeting of shareholders.

NEOGENOMICS INC

Report date August 10, 2023 · Filed August 14, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.82 · Expires 2033-08-10Direct8,353 Reported balance After 2023-08-10 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2023-08-10 · Grant · Acquired 8,353 · Balance 8,353

Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct11,336 Reported balance After 2023-08-10 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2023-08-10 · Grant · Acquired 11,336 · Balance 11,336

F1: Once vested, the shares of common stock are not subject to expiration.

Common StockSEC Table I · non-derivativeDirect65,120 Reported balance Holding disclosure · report date 2023-08-10 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 65,120

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.90 · Expires 2028-06-02Direct3,714 Reported balance Holding disclosure · report date 2023-08-10 · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · Balance 3,714

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.10 · Expires 2029-06-10Direct13,882 Reported balance Holding disclosure · report date 2023-08-10 · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · Balance 13,882

Filing footnotes · ownership attribution and instrument terms

F1: Once vested, the shares of common stock are not subject to expiration.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

WINTRUST FINANCIAL CORP

Report date December 31, 2022 · Filed January 03, 2023

Section 16 reporting ended · disclosed 2023-01-03. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect44,545 Reported balance After 2022-12-31 transaction · row 1
1 source row

Row 1 · 2022-12-31 · Grant · Acquired 686 · Balance 44,545

F1: Shares earned for the fourth quarter of 2022 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Filing footnotes · ownership attribution and instrument terms

F1: Shares earned for the fourth quarter of 2022 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 22, 2026 Filed Sep 24, 2026 21:00 UTC METHODE ELECTRONICS INC MEI · Entity 1870 GrantRestricted Stock Units · Derivative 9,186 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001244274-26-000002 · ownership.xml · derivative · entry 2

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,186

Underlying: Common Stock · 0 shares

Expires not disclosed

F1 · shares: Each restricted stock unit represents a contingent right to receive one share of Methode common stock upon vesting, granted under the Company's 2026 Omnibus Incentive Plan.

F2 · derivative.exercise_date: The restricted stock units vest in full on the date of the Company's 2027 annual meeting of shareholders.

F2 · derivative.expiration_date: The restricted stock units vest in full on the date of the Company's 2027 annual meeting of shareholders.

Read SEC document
September 16, 2025 Filed Sep 18, 2025 20:30 UTC METHODE ELECTRONICS INC MEI · Entity 1870 GrantCommon Stock 18,543 $8.00 $148,344.00
Disclosure

SEC source: 0001244274-25-000004 · ownership.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · In Trust

Disclosed balance after: 50,654

F1 · shares: Stock award granted under the terms of the Methode Electronics, Inc. 2022 Omnibus Incentive Plan with immediate vesting.

Read SEC document
June 13, 2024 Filed Jun 17, 2024 21:00 UTC METHODE ELECTRONICS INC MEI · Entity 1870 GrantCommon Stock 14,170 $9.88 $139,999.60
Disclosure

SEC source: 0000950170-24-074343 · ownership.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · In Trust

Disclosed balance after: 32,111

F1 · kind: Stock award granted under the terms of the Methode Electronics, Inc. 2022 Omnibus Incentive Plan.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:38 UTC NEOGENOMICS INC NEO · Entity 2096 GrantRestricted Stock Unit · Derivative 11,336 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001077183-23-000117 · wk-form4_1692049088.xml · derivative · entry 5

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,336

Underlying: Common Stock · 11,336 shares

Expires not disclosed

F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

Read SEC document
August 10, 2023 Filed Aug 14, 2023 21:38 UTC NEOGENOMICS INC NEO · Entity 2096 GrantStock Option (Right to Buy) · Derivative 8,353 $0.00 Strike: $14.82 $0.00
Disclosure

SEC source: 0001077183-23-000117 · wk-form4_1692049088.xml · derivative · entry 4

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,353

Underlying: Common Stock · 8,353 shares

Expires 2033-08-10

Read SEC document
July 05, 2023 Filed Jul 7, 2023 22:00 UTC METHODE ELECTRONICS INC MEI · Entity 1870 GrantCommon Stock 4,201 $33.33 $140,019.33
Disclosure

SEC source: 0001209191-23-041850 · doc4.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · In Trust

Disclosed balance after: 17,941

F1 · shares: Stock award granted under the terms of the Methode Electronics, Inc. 2022 Omnibus Incentive Plan.

Read SEC document
December 31, 2022 Filed Jan 3, 2023 21:12 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 686 $81.55 $55,943.30
Disclosure

SEC source: 0001015328-23-000013 · wf-form4_167278029930837.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,545

F1 · shares: Shares earned for the fourth quarter of 2022 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
September 30, 2022 Filed Oct 3, 2022 20:27 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 695 $80.15 $55,704.25
Disclosure

SEC source: 0001015328-22-000166 · wf-form4_166482883053673.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,859

F1 · shares: Shares earned for the third quarter of 2022 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
July 07, 2022 Filed Jul 11, 2022 21:00 UTC METHODE ELECTRONICS INC MEI · Entity 1870 GrantCommon Stock 3,885 $36.04 $140,015.40
Disclosure

SEC source: 0001209191-22-041806 · doc4.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · In Trust

Disclosed balance after: 13,740

F1 · shares: Restricted Stock Award granted under terms of the Methode Electronics, Inc. 2014 Stock Plan.

Read SEC document
June 30, 2022 Filed Jul 1, 2022 20:06 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 598 $92.93 $55,572.14
Disclosure

SEC source: 0001015328-22-000124 · wf-form4_165670597031982.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,164

F1 · shares: Shares earned for the second quarter of 2022 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
June 10, 2022 Filed Jun 15, 2022 00:42 UTC NEOGENOMICS INC NEO · Entity 2096 GrantStock Option (Right to Buy) · Derivative 13,882 $0.00 Strike: $8.10 $0.00
Disclosure

SEC source: 0001077183-22-000111 · wf-form4_165525374002565.xml · derivative · entry 3

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,882

Underlying: Common Stock · 13,882 shares

Expires 2029-06-10

Read SEC document
June 10, 2022 Filed Jun 15, 2022 00:42 UTC NEOGENOMICS INC NEO · Entity 2096 GrantCommon Stock 15,556 $0.00 $0.00
Disclosure

SEC source: 0001077183-22-000111 · wf-form4_165525374002565.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,120

Read SEC document
March 31, 2022 Filed Apr 1, 2022 20:22 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 609 $90.82 $55,309.38
Disclosure

SEC source: 0001015328-22-000073 · wf-form4_164884450766174.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,566

F1 · shares: Shares earned for the first quarter of 2022 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
December 31, 2021 Filed Jan 3, 2022 21:07 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 593 $80.37 $47,659.41
Disclosure

SEC source: 0001015328-22-000012 · wf-form4_164124400639597.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,957

F1 · shares: Shares earned for the fourth quarter of 2021 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
September 30, 2021 Filed Sep 30, 2021 20:31 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 627 $75.63 $47,420.01
Disclosure

SEC source: 0001015328-21-000174 · wf-form4_163303386547771.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,364

F1 · shares: Shares earned for the third quarter of 2021 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
July 07, 2021 Filed Jul 9, 2021 21:14 UTC METHODE ELECTRONICS INC MEI · Entity 1870 GrantCommon Stock 2,955 $47.39 $140,037.45
Disclosure

SEC source: 0001209191-21-046214 · doc4.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · In Trust

Disclosed balance after: 9,855

F1 · security: Restricted Stock Award granted under terms of the Methode Electronics, Inc. 2014 Stock Plan

Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:08 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 623 $75.80 $47,223.40
Disclosure

SEC source: 0001015328-21-000136 · wf-form4_162525649130487.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,737

F1 · shares: Shares earned for the second quarter of 2021 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:01 UTC NEOGENOMICS INC NEO · Entity 2096 Exercise / conversionStock Option (Right to Buy) · Derivative 3,448 $0.00 Strike: $28.54 $0.00
Disclosure

SEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · derivative · entry 9

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,448 shares

Expires 2027-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:01 UTC NEOGENOMICS INC NEO · Entity 2096 Exercise / conversionStock Option (Right to Buy) · Derivative 4,269 $0.00 Strike: $22.52 $0.00
Disclosure

SEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · derivative · entry 8

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,269 shares

Expires 2026-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:01 UTC NEOGENOMICS INC NEO · Entity 2096 Exercise / conversionStock Option (Right to Buy) · Derivative 3,017 $0.00 Strike: $11.60 $0.00
Disclosure

SEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · derivative · entry 7

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,017 shares

Expires 2023-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:01 UTC NEOGENOMICS INC NEO · Entity 2096 Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $7.27 $0.00
Disclosure

SEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · derivative · entry 6

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2022-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On May 25, 2017, Mr. Crowther was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:01 UTC NEOGENOMICS INC NEO · Entity 2096 SaleCommon Stock 20,734 $41.46 $859,631.64
Disclosure

SEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · nonDerivative · entry 5

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,564

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:01 UTC NEOGENOMICS INC NEO · Entity 2096 Exercise / conversionCommon Stock 3,448 $28.54 $98,405.92
Disclosure

SEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · nonDerivative · entry 4

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,298

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:01 UTC NEOGENOMICS INC NEO · Entity 2096 Exercise / conversionCommon Stock 4,269 $22.52 $96,137.88
Disclosure

SEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · nonDerivative · entry 3

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,850

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:01 UTC NEOGENOMICS INC NEO · Entity 2096 Exercise / conversionCommon Stock 3,017 $11.60 $34,997.20
Disclosure

SEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · nonDerivative · entry 2

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,581

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:01 UTC NEOGENOMICS INC NEO · Entity 2096 Exercise / conversionCommon Stock 10,000 $7.27 $72,700.00
Disclosure

SEC source: 0001077183-21-000166 · wf-form4_162335883900065.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,564

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 23:57 UTC NEOGENOMICS INC NEO · Entity 2096 GrantStock Option (Right to Buy) · Derivative 3,714 $0.00 Strike: $40.90 $0.00
Disclosure

SEC source: 0001077183-21-000157 · wf-form4_162285102497183.xml · derivative · entry 6

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,714

Underlying: Common Stock · 3,714 shares

Expires 2028-06-02

Read SEC document
June 02, 2021 Filed Jun 4, 2021 23:57 UTC NEOGENOMICS INC NEO · Entity 2096 GrantCommon Stock 3,081 $0.00 $0.00
Disclosure

SEC source: 0001077183-21-000157 · wf-form4_162285102497183.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,564

Read SEC document
March 31, 2021 Filed Mar 31, 2021 20:15 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 770 $61.09 $47,039.30
Disclosure

SEC source: 0001015328-21-000088 · wf-form4_161722172959085.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,114

F1 · shares: Shares earned for the first quarter of 2021 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:17 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 1,137 $40.05 $45,536.85
Disclosure

SEC source: 0001015328-21-000015 · wf-form4_160988142336145.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,344

F1 · shares: Shares earned for the fourth quarter of 2020 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
September 30, 2020 Filed Oct 1, 2020 21:14 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 1,036 $43.62 $45,190.32
Disclosure

SEC source: 0001015328-20-000193 · wf-form4_160158685420728.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,207

F1 · shares: Shares earned for the third quarter of 2020 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
September 24, 2020 Filed Sep 25, 2020 01:02 UTC NEOGENOMICS INC NEO · Entity 2096 Exercise / conversionStock Option (Right to Buy) · Derivative 8,333 $0.00 Strike: $9.11 $0.00
Disclosure

SEC source: 0001077183-20-000187 · wf-form4_160099571411498.xml · derivative · entry 4

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,333 shares

Expires 2021-07-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On July 28, 2016, Mr. Crowther was granted 8,333 stock options. The options vested ratably over the first three anniversary dates of the grant date.

Read SEC document
September 24, 2020 Filed Sep 25, 2020 01:02 UTC NEOGENOMICS INC NEO · Entity 2096 SaleCommon Stock 8,333 $35.01 $291,738.33
Disclosure

SEC source: 0001077183-20-000187 · wf-form4_160099571411498.xml · nonDerivative · entry 3

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,483

Read SEC document
September 24, 2020 Filed Sep 25, 2020 01:02 UTC NEOGENOMICS INC NEO · Entity 2096 Exercise / conversionCommon Stock 8,333 $9.11 $75,913.63
Disclosure

SEC source: 0001077183-20-000187 · wf-form4_160099571411498.xml · nonDerivative · entry 2

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,816

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 22, 2020 Filed Sep 25, 2020 01:02 UTC NEOGENOMICS INC NEO · Entity 2096 SaleCommon Stock 2,400 $35.68 $85,632.00
Disclosure

SEC source: 0001077183-20-000187 · wf-form4_160099571411498.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,483

Read SEC document
July 07, 2020 Filed Jul 9, 2020 23:53 UTC METHODE ELECTRONICS INC MEI · Entity 1870 GrantCommon Stock 3,000 $28.76 $86,280.00
Disclosure

SEC source: 0001209191-20-042049 · doc4.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · In Trust

Disclosed balance after: 6,900

F1 · shares: Restricted Stock Award granted under terms of the Methode Electronics, Inc. 2014 Omnibus Incentive Plan

Read SEC document
June 30, 2020 Filed Jul 2, 2020 21:20 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 1,365 $32.86 $44,853.90
Disclosure

SEC source: 0001015328-20-000148 · wf-form4_159372478916839.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,171

F1 · shares: Shares earned for the second quarter of 2020 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
May 28, 2020 Filed Jun 1, 2020 22:56 UTC NEOGENOMICS INC NEO · Entity 2096 GrantStock Options (Right to Buy) · Derivative 3,448 $0.00 Strike: $28.54 $0.00
Disclosure

SEC source: 0001077183-20-000130 · wf-form4_159105217191512.xml · derivative · entry 6

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,448

Underlying: Common Stock · 3,448 shares

Expires 2027-05-28

Read SEC document
May 28, 2020 Filed Jun 1, 2020 22:56 UTC NEOGENOMICS INC NEO · Entity 2096 GrantCommon Stock 2,698 $0.00 $0.00
Disclosure

SEC source: 0001077183-20-000130 · wf-form4_159105217191512.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,883

Read SEC document
May 01, 2020 Filed May 4, 2020 21:34 UTC NEOGENOMICS INC NEO · Entity 2096 Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $4.78 $0.00
Disclosure

SEC source: 0001077183-20-000110 · wf-form4_158862808205250.xml · derivative · entry 2

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2020-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On May 6, 2015 Mr. Crowther was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

Read SEC document
May 01, 2020 Filed May 4, 2020 21:34 UTC NEOGENOMICS INC NEO · Entity 2096 Exercise / conversionCommon Stock 10,000 $4.78 $47,800.00
Disclosure

SEC source: 0001077183-20-000110 · wf-form4_158862808205250.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,185

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 31, 2020 Filed Mar 31, 2020 20:23 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 630 $70.90 $44,667.00
Disclosure

SEC source: 0001015328-20-000102 · wf-form4_158568617026577.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,806

F1 · shares: Shares earned for the first quarter of 2020 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
December 31, 2019 Filed Jan 3, 2020 00:00 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 673 $64.63 $43,495.99
Disclosure

SEC source: 0001015328-20-000016 · wf-form4_157800963371970.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,176

F1 · shares: Shares earned for the fourth quarter of 2019 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
September 30, 2019 Filed Oct 1, 2019 21:01 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 593 $73.16 $43,383.88
Disclosure

SEC source: 0001015328-19-000161 · wf-form4_156996364166932.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,503

F1 · shares: Shares earned for the third quarter of 2019 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
September 04, 2019 Filed Sep 6, 2019 18:17 UTC METHODE ELECTRONICS INC MEI · Entity 1870 PurchaseCommon Stock 900 $31.58 $28,417.50
Disclosure

SEC source: 0001209191-19-048703 · doc4.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,900

Read SEC document
July 02, 2019 Filed Jul 8, 2019 23:52 UTC METHODE ELECTRONICS INC MEI · Entity 1870 GrantCommon Stock 3,000 $28.15 $84,450.00
Disclosure

SEC source: 0001209191-19-041491 · doc4.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

F1 · shares: Restricted Stock Award granted under terms of the Methode Electronics, Inc. 2014 Stock Plan

Read SEC document
June 30, 2019 Filed Jul 2, 2019 20:19 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 641 $67.33 $43,158.53
Disclosure

SEC source: 0001015328-19-000133 · wf-form4_156209875716035.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,910

F1 · shares: Shares earned for the second quarter of 2019 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document
June 06, 2019 Filed Jun 11, 2019 01:16 UTC NEOGENOMICS INC NEO · Entity 2096 GrantStock Options (Right to Buy) · Derivative 4,269 $0.00 Strike: $22.52 $0.00
Disclosure

SEC source: 0001077183-19-000109 · wf-form4_156021577116075.xml · derivative · entry 6

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,269

Underlying: Common Stock · 4,269 shares

Expires 2026-06-06

Read SEC document
June 06, 2019 Filed Jun 11, 2019 01:16 UTC NEOGENOMICS INC NEO · Entity 2096 GrantCommon Stock 3,419 $0.00 $0.00
Disclosure

SEC source: 0001077183-19-000109 · wf-form4_156021577116075.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,185

Read SEC document
March 31, 2019 Filed Apr 2, 2019 20:18 UTC WINTRUST FINANCIAL CORP WTFC · Entity 3524 GrantCommon Stock 646 $66.49 $42,952.54
Disclosure

SEC source: 0001015328-19-000088 · wf-form4_155423628572562.xml · nonDerivative · entry 1

CROWTHER BRUCE K · CIK 0001244274 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,269

F1 · shares: Shares earned for the first quarter of 2019 for services as a Director of the Company in accordance with the Director's Deferred Fee and Stock Plan approved by the Shareholders.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.